Kaiser Permanente Washington Health Research Institute, Seattle.
Department of Health Services, University of Washington, Seattle.
JAMA Netw Open. 2021 May 3;4(5):e219375. doi: 10.1001/jamanetworkopen.2021.9375.
Many people use cannabis for medical reasons despite limited evidence of therapeutic benefit and potential risks. Little is known about medical practitioners' documentation of medical cannabis use or clinical characteristics of patients with documented medical cannabis use.
To estimate the prevalence of past-year medical cannabis use documented in electronic health records (EHRs) and to describe patients with EHR-documented medical cannabis use, EHR-documented cannabis use without evidence of medical use (other cannabis use), and no EHR-documented cannabis use.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study assessed adult primary care patients who completed a cannabis screen during a visit between November 1, 2017, and October 31, 2018, at a large health system that conducts routine cannabis screening in a US state with legal medical and recreational cannabis use.
Three mutually exclusive categories of EHR-documented cannabis use (medical, other, and no use) based on practitioner documentation of medical cannabis use in the EHR and patient report of past-year cannabis use at screening.
Health conditions for which cannabis use has potential benefits or risks were defined based on National Academies of Sciences, Engineering, and Medicine's review. The adjusted prevalence of conditions diagnosed in the prior year were estimated across 3 categories of EHR-documented cannabis use with logistic regression.
A total of 185 565 patients (mean [SD] age, 52.0 [18.1] years; 59% female, 73% White, 94% non-Hispanic, and 61% commercially insured) were screened for cannabis use in a primary care visit during the study period. Among these patients, 3551 (2%) had EHR-documented medical cannabis use, 36 599 (20%) had EHR-documented other cannabis use, and 145 415 (78%) had no documented cannabis use. Patients with medical cannabis use had a higher prevalence of health conditions for which cannabis has potential benefits (49.8%; 95% CI, 48.3%-51.3%) compared with patients with other cannabis use (39.9%; 95% CI, 39.4%-40.3%) or no cannabis use (40.0%; 95% CI, 39.8%-40.2%). In addition, patients with medical cannabis use had a higher prevalence of health conditions for which cannabis has potential risks (60.7%; 95% CI, 59.0%-62.3%) compared with patients with other cannabis use (50.5%; 95% CI, 50.0%-51.0%) or no cannabis use (42.7%; 95% CI, 42.4%-42.9%).
In this cross-sectional study, primary care patients with documented medical cannabis use had a high prevalence of health conditions for which cannabis use has potential benefits, yet a higher prevalence of conditions with potential risks from cannabis use. These findings suggest that practitioners should be prepared to discuss potential risks and benefits of cannabis use with patients.
尽管有有限的治疗益处和潜在风险的证据,许多人出于医疗原因使用大麻。关于医疗从业者记录医疗大麻使用情况或有记录的医疗大麻使用者的临床特征,人们知之甚少。
估计电子健康记录(EHR)中记录的过去一年医疗大麻使用的流行率,并描述 EHR 中记录的医疗大麻使用者、EHR 中记录的大麻使用但没有证据表明医疗用途(其他大麻使用)和没有 EHR 记录的大麻使用的患者。
设计、设置和参与者:这项横断面研究评估了在一个大型医疗系统进行常规大麻筛查的美国州,在 2017 年 11 月 1 日至 2018 年 10 月 31 日期间进行就诊时完成大麻筛查的成年初级保健患者。
根据从业者在 EHR 中记录医疗大麻使用情况和患者在筛查时报告过去一年大麻使用情况,将 EHR 记录的大麻使用分为三个相互排斥的类别(医疗、其他和无使用)。
根据美国国家科学院、工程院和医学院的审查,定义了大麻使用具有潜在益处或风险的健康状况。使用逻辑回归对过去一年诊断的疾病的调整后患病率进行了估计,分为 3 类 EHR 记录的大麻使用。
在研究期间的一次初级保健就诊中,共有 185565 名患者(平均[SD]年龄,52.0[18.1]岁;59%为女性,73%为白人,94%为非西班牙裔,61%为商业保险)接受了大麻使用筛查。其中,3551 名(2%)患者有 EHR 记录的医疗大麻使用,36599 名(20%)患者有 EHR 记录的其他大麻使用,145415 名(78%)患者没有记录的大麻使用。与其他大麻使用者(39.9%;95%CI,39.4%-40.3%)或无大麻使用者(40.0%;95%CI,39.8%-40.2%)相比,有医疗大麻使用的患者有更高的潜在益处的健康状况患病率(49.8%;95%CI,48.3%-51.3%)。此外,与其他大麻使用者(50.5%;95%CI,50.0%-51.0%)或无大麻使用者(42.7%;95%CI,42.4%-42.9%)相比,有医疗大麻使用的患者有更高的潜在风险的健康状况患病率(60.7%;95%CI,59.0%-62.3%)。
在这项横断面研究中,有记录的医疗大麻使用的初级保健患者有很高的潜在益处的健康状况患病率,但潜在风险的疾病患病率更高。这些发现表明,从业者应该准备好与患者讨论大麻使用的潜在风险和益处。